<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>投行小兵 | wechat-feeds</title><link>http://MzIxOTUyMDQ0OQ.favicon.privacyhide.com/favicon.ico</link><description>既有小心求证，也有随性表达，关注热点，思考未来。认真、反思、交流、求解</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 12 May 2021 10:21:12 +0800</pubDate><image><url>http://MzIxOTUyMDQ0OQ.favicon.privacyhide.com/favicon.ico</url><title>投行小兵 | wechat-feeds</title><link>http://MzIxOTUyMDQ0OQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>【霍莱沃】原始报表的差异，多少比例可接受？</title><link>https://mp.weixin.qq.com/s/U3B11sssCJjJXvsESB-ppA</link><description></description><content:encoded><![CDATA[【霍莱沃】原始报表的差异，多少比例可接受？]]></content:encoded><pubDate>Tue, 11 May 2021 22:29:40 +0800</pubDate></item><item><title>【IPO一周】见缝插针审核，接下来速度会提升？</title><link>https://mp.weixin.qq.com/s/-cR0vJGs1Tgy36Da7suK1A</link><description></description><content:encoded><![CDATA[【IPO一周】见缝插针审核，接下来速度会提升？]]></content:encoded><pubDate>Tue, 11 May 2021 22:29:40 +0800</pubDate></item><item><title>注册制下混改国企IPO审核要点分析</title><link>https://mp.weixin.qq.com/s/rx8tglZX9-LqWoShgFTJgA</link><description></description><content:encoded><![CDATA[注册制下混改国企IPO审核要点分析]]></content:encoded><pubDate>Tue, 11 May 2021 22:29:40 +0800</pubDate></item><item><title>第74篇丨霍莱沃：非专职研发人员的薪酬怎么进研发费用？</title><link>https://mp.weixin.qq.com/s/QjSYSCYUS0h37SdUFSFErg</link><description></description><content:encoded><![CDATA[第74篇丨霍莱沃：非专职研发人员的薪酬怎么进研发费用？]]></content:encoded><pubDate>Mon, 10 May 2021 22:33:25 +0800</pubDate></item><item><title>比较靠谱的税务筹划方式和路径！</title><link>https://mp.weixin.qq.com/s/8CRueMoxNtUUa9giDaeoXg</link><description></description><content:encoded><![CDATA[比较靠谱的税务筹划方式和路径！]]></content:encoded><pubDate>Mon, 10 May 2021 22:33:25 +0800</pubDate></item><item><title>【热点评说】媒体和监管，请停止污名化中国的个人投资者吧</title><link>https://mp.weixin.qq.com/s/J2HxX0IdhuCteZe--a0tkw</link><description></description><content:encoded><![CDATA[【热点评说】媒体和监管，请停止污名化中国的个人投资者吧]]></content:encoded><pubDate>Mon, 10 May 2021 22:33:25 +0800</pubDate></item><item><title>第73篇丨富信科技：疫情之下，境外客户的核查替代程序和方式</title><link>https://mp.weixin.qq.com/s/k7j5LrkI_toS2uOLlspJDA</link><description></description><content:encoded><![CDATA[第73篇丨富信科技：疫情之下，境外客户的核查替代程序和方式]]></content:encoded><pubDate>Sun, 09 May 2021 20:03:51 +0800</pubDate></item><item><title>浅谈合作研发的会计处理</title><link>https://mp.weixin.qq.com/s/CsyH_bOBekOjvClmFwPIAQ</link><description></description><content:encoded><![CDATA[浅谈合作研发的会计处理]]></content:encoded><pubDate>Sun, 09 May 2021 20:03:51 +0800</pubDate></item><item><title>一票否决权等特殊权利条款的处理</title><link>https://mp.weixin.qq.com/s/-usUY5wmYgFUar6xWYub4Q</link><description></description><content:encoded><![CDATA[一票否决权等特殊权利条款的处理]]></content:encoded><pubDate>Sun, 09 May 2021 20:03:51 +0800</pubDate></item><item><title>重磅: 终于有人把所有医药细分行业及其重点公司彻底捋清楚了！</title><link>https://mp.weixin.qq.com/s/77kAD0ZrhYnKtArk6yTpJw</link><description></description><content:encoded><![CDATA[重磅: 终于有人把所有医药细分行业及其重点公司彻底捋清楚了！]]></content:encoded><pubDate>Fri, 07 May 2021 21:40:01 +0800</pubDate></item><item><title>注册制下混改国企IPO审核要点分析</title><link>https://mp.weixin.qq.com/s/wJGZcnnOC8hEDuaHwdo8Xw</link><description></description><content:encoded><![CDATA[注册制下混改国企IPO审核要点分析]]></content:encoded><pubDate>Fri, 07 May 2021 21:40:01 +0800</pubDate></item><item><title>【IPO审核】明天还上班，茅台酒招聘去看一看？</title><link>https://mp.weixin.qq.com/s/oReBfMJQElQvR_G79iPKbQ</link><description></description><content:encoded><![CDATA[【IPO审核】明天还上班，茅台酒招聘去看一看？]]></content:encoded><pubDate>Fri, 07 May 2021 21:40:01 +0800</pubDate></item><item><title>第72篇丨芳源股份：“明股实债”到底应该如何约定才最靠谱？</title><link>https://mp.weixin.qq.com/s/JGWS2XaewjZdjLYAiCqdXA</link><description></description><content:encoded><![CDATA[第72篇丨芳源股份：“明股实债”到底应该如何约定才最靠谱？]]></content:encoded><pubDate>Wed, 05 May 2021 22:01:38 +0800</pubDate></item><item><title>一票否决权等特殊权利条款的处理</title><link>https://mp.weixin.qq.com/s/UynN-1dFExax0UljyqPwoA</link><description></description><content:encoded><![CDATA[一票否决权等特殊权利条款的处理]]></content:encoded><pubDate>Wed, 05 May 2021 22:01:38 +0800</pubDate></item><item><title>【IPO一周】节后审核或将出现变化</title><link>https://mp.weixin.qq.com/s/BF6pFBuT--71srglQzEvkA</link><description></description><content:encoded><![CDATA[【IPO一周】节后审核或将出现变化]]></content:encoded><pubDate>Wed, 05 May 2021 22:01:38 +0800</pubDate></item><item><title>【5.22 深圳】投行小兵新书签售会暨IPO注册制讲座开始接受报名了</title><link>https://mp.weixin.qq.com/s/xvPtLd6shL_X2b8jWzEjSg</link><description></description><content:encoded><![CDATA[【5.22 深圳】投行小兵新书签售会暨IPO注册制讲座开始接受报名了]]></content:encoded><pubDate>Tue, 04 May 2021 21:39:00 +0800</pubDate></item><item><title>24小时删 | 限时分享这套精品课程，你将金融能力突飞猛涨！</title><link>https://mp.weixin.qq.com/s/Xm8V1Cqxvf5GXQUsb3RX0A</link><description></description><content:encoded><![CDATA[24小时删 | 限时分享这套精品课程，你将金融能力突飞猛涨！]]></content:encoded><pubDate>Tue, 04 May 2021 09:39:36 +0800</pubDate></item><item><title>非神也非魔！差异化分析沪深交易所现场督导制度的理念和原则！</title><link>https://mp.weixin.qq.com/s/Q_8BCHP8Y3K1O6-RNlYIwA</link><description></description><content:encoded><![CDATA[非神也非魔！差异化分析沪深交易所现场督导制度的理念和原则！]]></content:encoded><pubDate>Sat, 01 May 2021 13:16:56 +0800</pubDate></item><item><title>第71篇丨鼎阳科技：为了解决同业竞争，大股东减持股份至4.99%</title><link>https://mp.weixin.qq.com/s/azKORrxEOSVqJpS_XWQPcg</link><description></description><content:encoded><![CDATA[第71篇丨鼎阳科技：为了解决同业竞争，大股东减持股份至4.99%]]></content:encoded><pubDate>Wed, 28 Apr 2021 19:37:53 +0800</pubDate></item><item><title>实际控制人与老东家之间竞业禁止的核查</title><link>https://mp.weixin.qq.com/s/2giynvzHp80robyT63rLoA</link><description></description><content:encoded><![CDATA[实际控制人与老东家之间竞业禁止的核查]]></content:encoded><pubDate>Wed, 28 Apr 2021 19:37:53 +0800</pubDate></item></channel></rss>